Clinical Edge Journal Scan

Aging associated with seronegative RA in women


 

Key clinical point: Age is an independent contributor to seronegative rheumatoid arthritis (RA), with the effect being prominent in females but not in males.

Major finding: Rates of rheumatoid factor (RF) and anticyclic citrullinated peptide (anti-CCP) positivity and RF/anti-CCP double positivity declined significantly with an increase in age at RA diagnosis (all P < .001). The age at disease onset was independently associated with RF (odds ratio [OR] 0.980; P < .001) and anti-CCP (OR 0.976; P < .001) positivity in patients with RA, with both the associations being significant in women (RF positivity: OR 0.979; P < .001; anti-CCP positivity: OR 0.970; P < .001) but not in men.

Study details: This was a cohort study including 1685 patients with RA (mean age at diagnosis, 51.9 years), of which 83.4% were women.

Disclosures: This study did not receive any funding. The authors declared no conflict of interests.

Source: Takanashi S et al. Impacts of ageing on rheumatoid factor and anti-cyclic citrullinated peptide antibody positivity in patients with rheumatoid arthritis. J Rheumatol . 2022 (Nov 1). Doi: 10.3899/jrheum.220526

Recommended Reading

ACR introduces guideline for integrative interventions in RA
MDedge Rheumatology
Retention rates high after biosimilar-to-biosimilar switch for inflammatory arthritis
MDedge Rheumatology
Doctors urge screening for autoimmune disorders for patients with celiac disease
MDedge Rheumatology
Opioids increase risk for all-cause deaths in RA vs. NSAIDs
MDedge Rheumatology
StopRA trial: Hydroxychloroquine doesn’t prevent or delay onset of rheumatoid arthritis
MDedge Rheumatology
Celiac disease linked to higher risk for rheumatoid arthritis, juvenile idiopathic arthritis
MDedge Rheumatology
New ACR vaccination guideline: Take your best shot
MDedge Rheumatology
Treatment intensification benefits early RA nonresponders in COBRA treat-to-target trial
MDedge Rheumatology
Tocilizumab more effective than etanercept in suppressing progression of joint erosion in RA
MDedge Rheumatology
Seropositive RA: A strong risk factor for lung cancer
MDedge Rheumatology